General
Preferred name
VS-4718
Synonyms
PND-1186 ()
SR-2516 ()
PND 1186 ()
PND1186 ()
VS-4718 (hydrochloride) ()
SR-2516 (hydrochloride) ()
PND-1186 (hydrochloride) ()
PND-1186 (VS-4718) ()
SR-2156 ()
P&D ID
PD003237
CAS
1061353-68-1
1356154-94-3
Tags
available
drug candidate
Drug indication
Solid tumour/cancer
Drug Status
investigational
Max Phase
1.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION VS-4718 is an investigational, potent, reversible and orally active inhibitor of focal adhesion kinase (FAK; PTK2) . FAK inhibitors are being investigated for their anti-cancer effects due to the association of increased FAK expression with tumor progression, and the links between integrins and FAK in the adhesion pathways . (GtoPdb)
DESCRIPTION RIPK2 modulator; pro-drug of cRIPGM; orally bioavailable and brain penetrant (Tocris Bioactive Compound Library)
Cell lines
6
Organisms
0
Compound Sets
20
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
EUbOPEN Chemogenomics Library
Guide to Pharmacology
Kinase Inhibitors (best-in-class)
LINCS compound set
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
External IDs
27
Properties
(calculated by RDKit )
Molecular Weight
501.2
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
3
Rotatable Bonds
7
Ring Count
4
Aromatic Ring Count
3
cLogP
4.79
TPSA
87.75
Fraction CSP3
0.28
Chiral centers
0.0
Largest ring
6.0
QED
0.43
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
FAK
FAK/PYK2 inhibitor
Apoptosis related,FAK
Kinase group
TK
Pathway
Angiogenesis
Cytoskeletal Signaling
Tyrosine Kinase/Adaptors
Apoptosis
Protein Tyrosine Kinase/RTK
Primary Target
Focal Adhesion Kinase
MOA
Inhibitor
FAK inhibitor
focal adhesion kinase inhibitor
Member status
member
Recommended Cell Concentration
None
Source data